{"transactions":[{"id":704225,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":29042,"kind":"person","name":"DZAU VICTOR J","position":1,"cik":"0001201252","reported_name":"DZAU VICTOR J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-07-23T20:48:13.000Z","date":"2026-07-22","kind":"grant","planned":false,"acquired":true,"shares":2300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"In connection with Dr. Dzau's appointment to the Board of Directors on July 22, 2026, he was awarded restricted stock units and stock options in accordance with the Non-Employee Director Compensation Program, as follows: (a) 380 restricted stock units and 1,190 stock options, representing his initial grant upon joining the Board, and (b) 350 restricted stock units and 1,110 stock options, which are pro-rata grants representing the remainder of the 2026-2027 Board service year. Each award becomes fully vests on the one-year anniversary of the grant date."}],"balance_after":2300,"derivative":{"exercise_price":527.07,"exercise_date":"2027-07-22","expiration_date":"2033-07-22","underlying":"Common Stock","underlying_shares":2300},"source":{"system":"sec-edgar","filing":"0001201252-26-000010","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000120125226000010/primarydocument.xml","form_type":"4"}},{"id":704224,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":29042,"kind":"person","name":"DZAU VICTOR J","position":1,"cik":"0001201252","reported_name":"DZAU VICTOR J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-07-23T20:48:13.000Z","date":"2026-07-22","kind":"grant","planned":false,"acquired":true,"shares":730,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"In connection with Dr. Dzau's appointment to the Board of Directors on July 22, 2026, he was awarded restricted stock units and stock options in accordance with the Non-Employee Director Compensation Program, as follows: (a) 380 restricted stock units and 1,190 stock options, representing his initial grant upon joining the Board, and (b) 350 restricted stock units and 1,110 stock options, which are pro-rata grants representing the remainder of the 2026-2027 Board service year. Each award becomes fully vests on the one-year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable as restricted stock units do not have an expiration date."}],"balance_after":730,"derivative":{"exercise_price":0,"exercise_date":"2027-07-22","underlying":"Common Stock","underlying_shares":730},"source":{"system":"sec-edgar","filing":"0001201252-26-000010","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000120125226000010/primarydocument.xml","form_type":"4"}}]}